«Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: the Bezafibrate Infarction Prevention (BIP) study». Circulation. 102 (1): 21–7. 2000. PMID10880410. doi:10.1161/01.cir.102.1.21
Tenenbaum, A; Motro, M; Fisman, EZ; Tanne, D; Boyko, V; Behar, S (2005). «Bezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndrome». Archives of Internal Medicine. 165 (10): 1154–60. PMID15911729. doi:10.1001/archinte.165.10.1154
Tenenbaum, A; Motro, M; Fisman, EZ; Schwammenthal, E; Adler, Y; Goldenberg, I; Leor, J; Boyko, V; et al. (2004). «Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease». Circulation. 109 (18): 2197–202. PMID15123532. doi:10.1161/01.CIR.0000126824.12785.B6
Tenenbaum, A; Fisman, EZ; Boyko, V; Benderly, M; Tanne, D; Haim, M; Matas, Z; Motro, M; Behar, S (2006). «Attenuation of progression of insulin resistance in patients with coronary artery disease by bezafibrate». Archives of Internal Medicine. 166 (7): 737–41. PMID16606809. doi:10.1001/archinte.166.7.737
«Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: the Bezafibrate Infarction Prevention (BIP) study». Circulation. 102 (1): 21–7. 2000. PMID10880410. doi:10.1161/01.cir.102.1.21
Tenenbaum, A; Motro, M; Fisman, EZ; Tanne, D; Boyko, V; Behar, S (2005). «Bezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndrome». Archives of Internal Medicine. 165 (10): 1154–60. PMID15911729. doi:10.1001/archinte.165.10.1154
Tenenbaum, A; Motro, M; Fisman, EZ; Schwammenthal, E; Adler, Y; Goldenberg, I; Leor, J; Boyko, V; et al. (2004). «Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease». Circulation. 109 (18): 2197–202. PMID15123532. doi:10.1161/01.CIR.0000126824.12785.B6
Tenenbaum, A; Fisman, EZ; Boyko, V; Benderly, M; Tanne, D; Haim, M; Matas, Z; Motro, M; Behar, S (2006). «Attenuation of progression of insulin resistance in patients with coronary artery disease by bezafibrate». Archives of Internal Medicine. 166 (7): 737–41. PMID16606809. doi:10.1001/archinte.166.7.737